- Title
- A Phase II Trial of Oxaliplatin, Docetaxel, and Bevacizumab as First-Line Therapy of Advanced Cancer of the Ovary, Peritoneum, and Fallopian Tube
- Creators
- Thomas J. Herzog (Author)Bradley J. Monk (Author) - Creighton UniversityPeter G. Rose (Author)Patricia Braly (Author)Jeffrey F. Hines (Author)Maria C. Bell (Author)Robert M. Wenham (Author)Angeles A. Secord (Author)Lynda D. Roman (Author)Mark H. Einstein (Author)Richard D. Drake (Author)Barrett H. Childs (Author)
- Publication Details
- Gynecologic Oncology, Vol.132(3), pp.517-525
- Number of pages
- 517-525
- Identifiers
- 991005931731202656
- Academic Unit
- School of Medicine; Obstetrics & Gynecology
- Resource Type
- Journal article
Journal article
A Phase II Trial of Oxaliplatin, Docetaxel, and Bevacizumab as First-Line Therapy of Advanced Cancer of the Ovary, Peritoneum, and Fallopian Tube
Gynecologic Oncology, Vol.132(3), pp.517-525
03/2013
Metrics
10 Record Views